Secondary power meter for quarter-cycle power measurement and invoicing method
    5.
    发明授权
    Secondary power meter for quarter-cycle power measurement and invoicing method 有权
    二次功率计,用于四分之一周期功率测量和发票方法

    公开(公告)号:US08260695B1

    公开(公告)日:2012-09-04

    申请号:US12835798

    申请日:2010-07-14

    申请人: Steven Rosenberg

    发明人: Steven Rosenberg

    IPC分类号: G07F19/00

    CPC分类号: G01R21/133

    摘要: The disclosed technology comprises a device and a method for accurately determining the amount of electrical energy utilized in a circuit with a quarter-cycle transformer and transducers operating off quarter-cycle power. The method allows for a primary power meter associated with an entity which provides a power source to remain in operation, without modification, and for a second power meter to be utilized which accurately measures consumption of quarter-cycle power usage. An adjustment to an invoice can then be made, based on the difference.

    摘要翻译: 所公开的技术包括用于精确地确定在具有四分之一周期的变压器的电路中使用的电能的量的装置和方法,以及四分之一周期功率的换能器。 该方法允许与实体相关联的主功率计,该实体提供电源以保持运行,而不进行修改,以及为了精确地测量四分之一周期功率使用的消耗而使用的第二功率计。 然后可以根据差异对发票进行调整。

    MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS
    10.
    发明申请
    MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS 有权
    MELANOMA抗原及其在诊断和治疗方法中的应用

    公开(公告)号:US20070259422A1

    公开(公告)日:2007-11-08

    申请号:US11772277

    申请日:2007-07-02

    摘要: The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen-and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.

    摘要翻译: 本发明提供编码被称为MART-1的T淋巴细胞识别的黑素瘤抗原的核酸序列。 本发明还涉及使用本发明的核酸序列,蛋白质或抗体诊断,评估或预测患有黑素瘤或转移性黑素瘤的哺乳动物的生物测定。 本发明还提供了衍生自MART-1黑素瘤抗原的免疫原性肽和称为gp100的第二种黑素瘤抗原。 本发明还提供衍生自MART-1黑素瘤抗原或gp100抗原的免疫原性肽,其已被修饰以增强其免疫原性。 所提供的蛋白质和肽可以作为预防或治疗黑素瘤的免疫原或疫苗。